A study supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), with supplemental funding from the National Institute on Drug Abuse (NIDA), has examined inflammatory marker profiles in adolescents and young adults across the HIV risk, infection, and treatment spectrum. The research highlights how inflammation varies among individuals at different stagesβfrom those at risk of HIV to those living with the virus and receiving treatment.
According to the authors, the work was made possible through financial support for both the research and its publication. The study adds to the growing body of evidence on how HIV and its treatment influence immune activation and inflammation in younger populations, who represent a significant proportion of new HIV infections globally.
While the full details of the study's findings are not yet publicly available, the research underscores the importance of understanding inflammatory processes in adolescents and young adults. This age group often faces unique challenges in HIV prevention and care, and tailored interventions may be needed to address their specific health needs.
The involvement of NICHD and NIDA reflects ongoing federal investment in HIV research, particularly among youth. As of 2026, HIV remains a global health priority, with an estimated 1.3 million new infections in 2024, according to UNAIDS. Studies like this one contribute to the scientific foundation for developing more effective prevention and treatment strategies.
